# Syndax Pharmaceuticals Inc. (SNDX) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$273M |
| 2024 | -$340M |
| 2023 | -$230M |
| 2022 | -$152M |
| 2021 | $26M |
| 2020 | -$71M |
| 2019 | -$58M |
| 2018 | -$76M |
| 2017 | -$62M |
| 2016 | -$44M |
| 2015 | -$21M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$34M |
| 2025-09-30 | -$57M |
| 2025-06-30 | -$69M |
| 2025-03-31 | -$84M |
| 2024-09-30 | -$90M |
| 2024-06-30 | -$74M |
| 2024-03-31 | -$80M |
| 2023-09-30 | -$56M |
| 2023-06-30 | -$50M |
| 2021-09-30 | -$20M |
| 2021-06-30 | -$22M |
| 2021-03-31 | -$27M |
| 2020-09-30 | -$20M |
| 2020-06-30 | -$17M |
| 2020-03-31 | -$15M |
| 2019-09-30 | -$13M |
| 2019-06-30 | -$15M |
| 2019-03-31 | -$15M |
| 2018-09-30 | -$18M |
| 2018-06-30 | -$19M |
| 2018-03-31 | -$20M |
| 2017-09-30 | -$15M |
| 2017-06-30 | -$14M |
| 2017-03-31 | -$13M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/SNDX/operating-income)